comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 21:10:09 - browse：9

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： One Duchenne patient's bittersweet hope for new treatment

knowledge

WSS

Scientists grapple with ethics of stem cell research

Sanders wants to replace patents with prizes for drug inventions

There’s a way to spot data fakery. All journals should be using it

France's anti

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Inflation cooled significantly in June, bringing price hikes close to normal levels

knowledge

comprehensive

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Jerome Adams on the need for new antivirals for Covid

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Moonlake's readout produced a cash windfall. Risks remain

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Anesthesiologist group: stop taking Ozempic before surgery

One Duchenne patient's bittersweet hope for new treatment

Sports medicine is finally prioritizing gender equality

How are insurers handling Leqembi and related scans?

leisure time

How are insurers handling Leqembi and related scans?

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Digital health funding stays low as a new reality sets in

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

A new ‘biological computer' targets cancer while sparing healthy cells

Wikipedia

knowledge

knowledge

entertainment